Fang Wu

685 total citations
28 papers, 528 citations indexed

About

Fang Wu is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Fang Wu has authored 28 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 6 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Fang Wu's work include RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related gene regulation (4 papers). Fang Wu is often cited by papers focused on RNA modifications and cancer (5 papers), Cancer-related molecular mechanisms research (4 papers) and Cancer-related gene regulation (4 papers). Fang Wu collaborates with scholars based in China, United States and Canada. Fang Wu's co-authors include Tsuyoshi Okuda, Stephen B. Howell, Xinjian Lin, Han Yang, Xixi He, Lihao Zhao, Raymond Lai, Leah C. Young, Junli Ding and Min Xia and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Cancer Research.

In The Last Decade

Fang Wu

26 papers receiving 518 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fang Wu China 14 431 178 100 53 48 28 528
Leilei Niu China 12 425 1.0× 215 1.2× 106 1.1× 68 1.3× 39 0.8× 21 602
Asmitananda Thakur China 15 356 0.8× 198 1.1× 91 0.9× 41 0.8× 69 1.4× 25 507
Z. Peter Wang China 14 390 0.9× 128 0.7× 121 1.2× 36 0.7× 31 0.6× 18 524
George Sai‐Wah Tsao Hong Kong 11 313 0.7× 129 0.7× 133 1.3× 41 0.8× 53 1.1× 22 520
Junjian Deng China 12 275 0.6× 173 1.0× 99 1.0× 29 0.5× 44 0.9× 24 399
Zumin Xu China 13 294 0.7× 141 0.8× 109 1.1× 31 0.6× 44 0.9× 24 427
Po-Lin Lin Taiwan 12 382 0.9× 161 0.9× 143 1.4× 42 0.8× 61 1.3× 17 539

Countries citing papers authored by Fang Wu

Since Specialization
Citations

This map shows the geographic impact of Fang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Wu more than expected).

Fields of papers citing papers by Fang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Wu. The network helps show where Fang Wu may publish in the future.

Co-authorship network of co-authors of Fang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Wu. A scholar is included among the top collaborators of Fang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Wu. Fang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Wang, Zhiqiang, Jian Xie, Fang Wu, et al.. (2025). Lycium barbarum polysaccharide LBP-4 attenuates triptolide-induced male reproductive toxicity via Nrf2/Keap1-mediated antioxidant response and apoptotic regulation. Journal of Ethnopharmacology. 355(Pt B). 120682–120682.
3.
Gao, Ying, Junyang Wang, Xin Zhang, et al.. (2024). Predictive Role of Elevated Neutrophil-Lymphocyte Ratio for Bone Metastasis in Esophageal Cancer. Technology in Cancer Research & Treatment. 23. 2234013931–2234013931. 1 indexed citations
4.
Zhao, Jungang, Chao Chen, Huajun Ye, et al.. (2024). Enhanced PSO feature selection with Runge-Kutta and Gaussian sampling for precise gastric cancer recurrence prediction. Computers in Biology and Medicine. 175. 108437–108437. 2 indexed citations
5.
Chen, Ziyan, Haitao Yu, Lijun Wu, et al.. (2021). Identification and Validation of Hub Genes Predicting Prognosis of Hepatocellular Carcinoma. Digestive Surgery. 39(1). 24–31. 1 indexed citations
6.
Xia, Yiqun, Yun Yu, Fengjiao Wu, et al.. (2021). Compensatory combination of mTOR and TrxR inhibitors to cause oxidative stress and regression of tumors. Theranostics. 11(9). 4335–4350. 22 indexed citations
7.
Zhao, Lihao, Quan Li, Zhijun Huang, et al.. (2021). Identification of histone methyltransferase NSD2 as an important oncogenic gene in colorectal cancer. Cell Death and Disease. 12(11). 974–974. 33 indexed citations
8.
Chen, Qin, Wen-Ying Yu, Huan‐Huan Zhang, et al.. (2020). PBX3 Promotes Tumor Growth and Angiogenesis via Activation of AT1R/VEGFR2 Pathway in Papillary Thyroid Carcinoma. BioMed Research International. 2020(1). 8954513–8954513. 8 indexed citations
9.
Lin, Hong, Fang Wu, Fengjiao Wu, et al.. (2020). Isodeoxyelephantopin Inactivates Thioredoxin Reductase 1 and Activates ROS-Mediated JNK Signaling Pathway to Exacerbate Cisplatin Effectiveness in Human Colon Cancer Cells. Frontiers in Cell and Developmental Biology. 8. 580517–580517. 16 indexed citations
10.
Li, Gang, et al.. (2019). Ninjurin 2 overexpression promotes human colorectal cancer cell growth in vitro and in vivo. Aging. 11(19). 8526–8541. 28 indexed citations
11.
Wu, Fang, Fang Liu, Han Yang, et al.. (2018). miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling. Cancer Letters. 435. 1–9. 46 indexed citations
12.
Guo, Pengyi, Yi Wang, Fang Wu, et al.. (2017). Ribosomal protein S15a promotes tumor angiogenesis via enhancing Wnt/β-catenin-induced FGF18 expression in hepatocellular carcinoma. Oncogene. 37(9). 1220–1236. 54 indexed citations
13.
Xia, Min, Fang Wu, Junli Ding, et al.. (2017). Upregulated exosomic miR-23b-3p plays regulatory roles in the progression of pancreatic cancer. Oncology Reports. 38(4). 2182–2188. 57 indexed citations
14.
Wu, Fang, Yizhi Liu, Jian Li, et al.. (2016). Human serum albumin-mediated apoptin delivery suppresses breast cancer cell growth in vitro and in vivo. Oncology Letters. 13(2). 579–586. 11 indexed citations
15.
Sun, Hongwei, Xiaoli Wu, Fang Wu, et al.. (2015). Associations of Genetic Variants in the PSCA, MUC1 and PLCE1 Genes with Stomach Cancer Susceptibility in a Chinese Population. PLoS ONE. 10(2). e0117576–e0117576. 26 indexed citations
16.
Chen, Tian, Chen Wang, Fang Wu, et al.. (2015). Altered Localization of p120 Catenin in the Cytoplasm Rather than the Membrane Correlates with Poor Prognosis in Esophageal Squamous Cell Carcinoma. PLoS ONE. 10(3). e0118645–e0118645. 15 indexed citations
17.
Tao, Hou‐Quan, Sheng Yu, Xujun He, et al.. (2014). Involvement of c-KIT mutation in the development of gastrointestinal stromal tumors through proliferation promotion and apoptosis inhibition. OncoTargets and Therapy. 7. 637–637. 13 indexed citations
18.
Wang, Peng, Fang Wu, Xiaoxia Ye, et al.. (2012). The expression and oncogenic effects of the embryonic stem cell marker SALL4 in ALK-positive anaplastic large cell lymphoma. Cellular Signalling. 24(10). 1955–1963. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026